Abstract
Purpose
The purpose of this study was to analyze the efficacy and complication rates of a one-stage left unilateral thoracoscopic hybrid procedure in a series of patients with persistent and long-standing persistent atrial fibrillation (AF) in a 2-year follow-up.
Methods
Fifty-one consecutive patients (34 males, 65.7 ± 8 years) having undergone hybrid isolation of pulmonary veins (PVs) and posterior wall of left atrium (LA) by means of left unilateral hybrid thoracoscopic ablation for symptomatic persistent (n = 22, 43%) and long-standing persistent atrial fibrillation (AF) (n = 29, 57%) were analyzed.
Results
At a mean follow-up of 24.9 ± 11.8 months (median 24), the success rate without antiarrhythmic therapy was achieved in 68.6% of patients. Procedure-related major complications were observed in 2 patients (4%) including diaphragmatic perforation and late pericardial tamponade requiring mini left-sided thoracotomy and pericardial drainage, respectively. The success rate did not significantly differ between persistent and long-standing persistent AF (respectively, 68.2 and 69%; P = 0.89). Patients with AF relapse during the blanking period were 3.8 times more likely to have AF recurrence after 3 months from the ablation procedure.
Conclusion
The hybrid one-stage left unilateral thoracoscopic procedure exhibits encouraging results in the setting of both persistent and long-standing persistent AF after a 2-year follow-up, at a low rate of adverse events.
Similar content being viewed by others
Change history
17 January 2020
Owing to a type error during final correction and proof data submission to the journal, there were mistakes introduced into the legends of Fig. 3 and Fig. 4 as well as into the Y-axis title of the plot of Fig. 4.
References
Lee G, Sanders P, Kalman JM. Catheter ablation of atrial arrhythmias: state of the art. Lancet (London, England). 2012;380(9852):1509–19. https://doi.org/10.1016/S0140-6736(12)61463-9.
Kirchhof P, Calkins H. Catheter ablation in patients with persistent atrial fibrillation. Eur Heart J. 2017;38(1):20–6. https://doi.org/10.1093/eurheartj/ehw260.
Weimar T, Schena S, Bailey MS, Maniar HS, Schuessler RB, Cox JL, et al. The Cox-Maze procedure for lone atrial fibrillation: a single-center experience over 2 decades. Circ Arrhythm Electrophysiol. 2012;5(1):8–14. https://doi.org/10.1161/CIRCEP.111.963819.
La Meir M, Gelsomino S, Lucà F, Pison L, Colella A, Lorusso R, et al. Minimal invasive surgery for atrial fibrillation: an updated review. Europace. 2013;15(2):170–82. https://doi.org/10.1093/europace/eus216.
Gaynor SL, Diodato MD, Prasad SM, Ishii Y, Schuessler RB, Bailey MS, et al. A prospective, single-center clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation. J Thorac Cardiovasc Surg. 2004;128(4):535–42. https://doi.org/10.1016/j.jtcvs.2004.02.044.
Wolf RK, Schneeberger EW, Osterday R, Miller D, Merrill W, Flege JB, et al. Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. J Thorac Cardiovasc Surg. 2005;130(3):797–802. https://doi.org/10.1016/j.jtcvs.2005.03.041.
Calkins H, Kuck K-H, Cappato R, Brugada J, Camm AJ, Chen S-A, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012;14(4):528–606. https://doi.org/10.1093/europace/eus027.
Calkins H, Hindricks G, Cappato R, Kim Y-H, Saad EB, Aguinaga L, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2018;20(1):e1–e160. https://doi.org/10.1093/europace/eux274.
de Asmundis C, Chierchia GB, Mugnai G, Van Loo I, Nijs J, Czapla J, et al. Midterm clinical outcomes of concomitant thoracoscopic epicardial and transcatheter endocardial ablation for persistent and long-standing persistent atrial fibrillation: a single-centre experience. Europace. 2017;19(1):58–65. https://doi.org/10.1093/europace/euw026.
Pison L, La Meir M, van Opstal J, Blaauw Y, Maessen J, Crijns HJ. Hybrid thoracoscopic surgical and transvenous catheter ablation of atrial fibrillation. J Am Coll Cardiol. 2012;60(1):54–61. https://doi.org/10.1016/j.jacc.2011.12.055.
Moritz A, Irouschek A, Birkholz T, Prottengeier J, Sirbu H, Schmidt J. The EZ-blocker for one-lung ventilation in patients undergoing thoracic surgery: clinical applications and experience in 100 cases in a routine clinical setting. J Cardiothorac Surg. 2018;13(1):77. https://doi.org/10.1186/s13019-018-0767-9.
Pak H-N, Hwang C, Lim HE, Kim JS, Kim Y-H. Hybrid epicardial and endocardial ablation of persistent or permanent atrial fibrillation: a new approach for difficult cases. J Cardiovasc Electrophysiol. 2007;18(9):917–23. https://doi.org/10.1111/j.1540-8167.2007.00882.x.
Mahapatra S, LaPar DJ, Kamath S, Payne J, Bilchick KC, Mangrum JM, et al. Initial experience of sequential surgical epicardial-catheter endocardial ablation for persistent and long-standing persistent atrial fibrillation with long-term follow-up. Ann Thorac Surg. 2011;91(6):1890–8. https://doi.org/10.1016/j.athoracsur.2011.02.045.
Kurfirst V, Mokraček A, Bulava A, Čanadyova J, Haniš J, Pešl L. Two-staged hybrid treatment of persistent atrial fibrillation: short-term single-centre results. Interact Cardiovasc Thorac Surg. 2014;18(4):451–6. https://doi.org/10.1093/icvts/ivt538.
Muneretto C, Bisleri G, Bontempi L, Curnis A. Durable staged hybrid ablation with thoracoscopic and percutaneous approach for treatment of long-standing atrial fibrillation: a 30-month assessment with continuous monitoring. J Thorac Cardiovasc Surg. 2012;144(6):1460–5, discussion 1465. https://doi.org/10.1016/j.jtcvs.2012.08.069.
Muneretto C, Bisleri G, Rosati F, Krakor R, Giroletti L, Di Bacco L, et al. European prospective multicentre study of hybrid thoracoscopic and transcatheter ablation of persistent atrial fibrillation: the HISTORIC-AF trial. Eur J Cardio Thorac Surg. 2017;52(4):740–5. https://doi.org/10.1093/ejcts/ezx162.
Budera P, Osmancik P, Talavera D, Kraupnerova A, Fojt R, Zdarska J, et al. Two-staged hybrid ablation of non-paroxysmal atrial fibrillation: clinical outcomes and functional improvements after 1 year. Interact Cardiovasc Thorac Surg. 2018;26(1):77–83. https://doi.org/10.1093/icvts/ivx248.
Zembala M, Filipiak K, Kowalski O, Buchta P, Niklewski T, Nadziakiewicz P, et al. Staged hybrid ablation for persistent and longstanding persistent atrial fibrillation effectively restores sinus rhythm in long-term observation. Arch Med Sci. 2017;13(1):109–17. https://doi.org/10.5114/aoms.2015.53960.
Maesen B, Pison L, Vroomen M, Luermans JG, Vernooy K, Maessen JG, et al. Three-year follow-up of hybrid ablation for atrial fibrillation. Eur J Cardio Thorac Surg. 2018;53(suppl_1):i26–32. https://doi.org/10.1093/ejcts/ezy117.
Gehi AK, Mounsey JP, Pursell I, Landers M, Boyce K, Chung EH, et al. Hybrid epicardial-endocardial ablation using a pericardioscopic technique for the treatment of atrial fibrillation. Heart Rhythm. 2013;10(1):22–8. https://doi.org/10.1016/j.hrthm.2012.08.044.
Boersma LVA, Castella M, van Boven W, Berruezo A, Yilmaz A, Nadal M, et al. Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial. Circulation. 2012;125(1):23–30. https://doi.org/10.1161/CIRCULATIONAHA.111.074047.
Kress DC, Erickson L, Choudhuri I, Zilinski J, Mengesha T, Krum D, et al. Comparative effectiveness of hybrid ablation versus endocardial catheter ablation alone in patients with persistent atrial fibrillation. JACC Clin Electrophysiol. 2017;3(4):341–9. https://doi.org/10.1016/j.jacep.2016.10.010.
Pison L, Gelsomino S, Lucà F, Parise O, Maessen JG, Crijns HJGM, et al. Effectiveness and safety of simultaneous hybrid thoracoscopic and endocardial catheter ablation of lone atrial fibrillation. Ann Cardiothorac Surg. 2014;3(1):38–44. https://doi.org/10.3978/j.issn.2225-319X.2013.12.10.
Dzeshka MS, Lip GYH, Snezhitskiy V, Shantsila E. Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications. J Am Coll Cardiol. 2015;66(8):943–59. https://doi.org/10.1016/j.jacc.2015.06.1313.
Velagic V, de Asmundis C, Mugnai G, Irfan G, Hunuk B, Ströker E, et al. Repeat procedures after hybrid thoracoscopic ablation in the setting of longstanding persistent atrial fibrillation: electrophysiological findings and 2-year clinical outcome. J Cardiovasc Electrophysiol. 2016;27(1):41–50. https://doi.org/10.1111/jce.12837.
Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Mohanty S, Horton R, et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation. 2010;122(2):109–18. https://doi.org/10.1161/CIRCULATIONAHA.109.928903.
Di Biase L, Burkhardt JD, Mohanty P, Mohanty S, Sanchez JE, Trivedi C, et al. Left atrial appendage isolation in patients with longstanding persistent AF undergoing catheter ablation: BELIEF trial. J Am Coll Cardiol. 2016;68(18):1929–40. https://doi.org/10.1016/j.jacc.2016.07.770.
Pearman CM, Poon SS, Bonnett LJ, Haldar S, Wong T, Mediratta N, et al. Minimally invasive epicardial surgical ablation alone versus hybrid ablation for atrial fibrillation: a systematic review and meta-analysis. Arrhythmia Electrophysiol Rev. 2017;6(4):202–9. https://doi.org/10.15420/aer/2017.29.2.
Je HG, Shuman DJ, Ad N. A systematic review of minimally invasive surgical treatment for atrial fibrillation: a comparison of the Cox-Maze procedure, beating-heart epicardial ablation, and the hybrid procedure on safety and efficacy. Europace. 2015;48(4):531–40, discussion 540–1. https://doi.org/10.1093/ejcts/ezu536.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
CdA receives compensation for teaching purposes and proctoring from AF Solutions, Medtronic, Abbott, Biotronik, and Atricure, and research grants on behalf of the center from Biotronik, Medtronic, St Jude Medical Abbot, Livanova, Boston Scientific, Biosense Webster, Atricure, and CardioTek. GBC receives compensation for teaching purposes and proctoring from AF Solutions and Medtronic. PB receives and speakers fees from Biotronik and Medtronic. MLM is a consultant for Atricure.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
de Asmundis, C., Varnavas, V., Sieira, J. et al. Two-year follow-up of one-stage left unilateral thoracoscopic epicardial and transcatheter endocardial ablation for persistent and long-standing persistent atrial fibrillation. J Interv Card Electrophysiol 58, 333–343 (2020). https://doi.org/10.1007/s10840-019-00616-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-019-00616-w